Research Article
Seroprevalence of Hepatitis C, Hepatitis B, Cytomegalovirus, and Human Immunodeficiency Viruses in Multitransfused Thalassemic Children in Upper Egypt
Table 5
Risk factors for CMV.
| | Risk factors | | CMV | value | | No () | Yes () |
| | Age/years | Mean (SD) | 8.69 (6.01) | 13.63 (4.21) | 0.03 | | Median (range) | 10 (1–21) | 15 (6.5–18) |
| | Gender | Females | 32 (34.41%) | 3 (75.00%) | 0.14 | | Males | 61 (65.59%) | 1 (25.00%) |
| | Duration of the disease/years | Mean (SD) | 7.82 (4.92) | 13.69 (3.79) | 0.03 |
| | Frequency of blood transfusion/months | Mean (SD) | 1.09 (0.43) | 0.88 (0.25) | 0.21 |
| | Splenectomy | No | 55 (59.14%) | 1 (25.00%) | 0.31 | | Yes | 38 (40.86%) | 3 (75.00%) |
| | Ferritin level (ng/dL) | Mean (SD) | 2894 (1770) | 4735 (1789) | 0.04 |
| | Alanine transaminase (ALT) (U/L) | Mean (SD) | 55 (3.4) | 56 (3.7) | 0.43 |
| | Aspartate aminotransferase (AST) (U/L) | Mean (SD) | 50 (6.44) | 54 (6.8) | 0.14 |
|
|
values were obtained by using Mann-Whitney test, Chi-square test, or Fisher exact test.
|
